Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000326913 | SCV000343606 | uncertain significance | not provided | 2016-07-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000702797 | SCV000831667 | uncertain significance | Brugada syndrome 8 | 2024-09-23 | criteria provided, single submitter | clinical testing | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 852 of the HCN4 protein (p.Pro852Leu). This variant is present in population databases (rs779241036, gnomAD 0.003%). This missense change has been observed in individual(s) with dilated cardiomyopathy and atrioventricular block (PMID: 28254188). ClinVar contains an entry for this variant (Variation ID: 289273). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt HCN4 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Fulgent Genetics, |
RCV002480042 | SCV002780808 | uncertain significance | Sick sinus syndrome 2, autosomal dominant; Brugada syndrome 8; Epilepsy, idiopathic generalized, susceptibility to, 18 | 2021-10-19 | criteria provided, single submitter | clinical testing |